Investigation of Cebpa and Cebpa-As Genes Expression in Acute Myeloid Leukemia

Investigation of Cebpa and Cebpa-As Genes Expression in Acute Myeloid Leukemia

Gholami M¹ ; Bayat S² ; Manoochehrabadi S^{1, 3} ; Pashaiefar H⁴ ; Omrani MD¹ ; Jalaeikhoo H⁵ ; Yassaee VR⁶ ; Ebrahimpour MR⁷ ; Behjati F⁷ ; Mirfakhraie R^{1, 6}

Show Affiliations

1. Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2. Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
3. Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
5. AJA Cancer Research Center (ACRC), AJA University of Medical Sciences, Tehran, Iran
6. Genomic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
7. Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran

Source: Reports of Biochemistry and Molecular Biology Published:2019

Abstract

Background: The pathogenicity of acute myeloid leukemia (AML) is highly influenced by genetic alterations, such as chromosomal abnormalities. Additionally, aberrations in the mechanisms involved in gene expression have been identified to have a role in the development of AML. Contradictory evidence has been reported concerning the expression of the CEBPA gene in AML patients. Additionally, investigation into the expression of the CEBPA-AS gene has yet to be explored in AML patients. The aim of the present study was to investigate the relationship between the expression of the CEBPA and CEBPA-AS genes and AML in Iranian patients. Methods: Using quantitative real-time PCR, the expression of the CEBPA and CEBPA-AS genes was examined in the peripheral blood samples of 58 patients with de novo adult AML, and in 20 healthy controls. Results: Overall, CEBPA expression analysis showed a significant up-regulation in AML patients compared with healthy controls. Interestingly, a significant up-regulation of CEBPA was detected in the male AML patients. Significant CEBPA over-expression was observed in M0 (p-value=0.0001), M3 (p-value= 0.012) and M4 (pvalue= 0.000) FAB subtypes. Our data has also demonstrated that CEBPA expression is up-regulated in favorable (p-value= 0.006) and adverse (p-value= 0.042) cytogenetic risk groups. In addition, the expression of CEBPA was significantly increased in AML patients with an abnormal karyotype. Ectopic expression of CEBPA-AS was detected in seven of the AML patients. Conclusions: Our study provides evidence for the up-regulation of CEBPA and the ectopic expression of CEBPA-AS in AML patients, suggesting that these two genes may play an important role in the pathogenesis of AML. The role of CEBPA and CEBPA-AS in AML patients should be further explored. This will offer potential opportunities for the development of novel treatment strategies. © 2015 Reports of Biochemistry and Molecular Biology.

Related Docs

View other Related Docs

1. Mutational Screening of Rtk-Braf Genes in De Novo Adult Acute Myeloid Leukemia, Gene Reports (2020)

2. Genetic, Hematologic and Psychological Aspects of Leukemia, Cancer Genetics and Psychotherapy (2017)

3. Reinforcing the Primary Immunotherapy Modulators Against Acute Leukemia; Monoclonal Antibodies in Aml, Immunotherapy (2019)

4. Ultrasensitive Quantitation of Flt3-Itd Mutation in Patients With Acute Myeloid Leukemia Using Ddpcr, Molecular Biology Reports (2023)

5. Studying the Potential of Upregulated Ptgs2 and Vegf-C Besides Hyper-Methylation of Ptgs2 Promoter As Biomarkers of Acute Myeloid Leukemia, Molecular Biology Reports (2022)

6. Toll-Like Receptor 4 Signaling Pathway Is Correlated With Pathophysiological Characteristics of Aml Patients and Its Inhibition Using Tak-242 Suppresses Aml Cell Proliferation, International Immunopharmacology (2021)

7. Rad51 and Rad50 Genetic Polymorphisms From Homologous Recombination Repair Pathway Are Associated With Disease Outcomes and Organ Toxicities in Aml, Blood Research (2024)

8. Transplantation, Clinical Immunology (2022)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (3)

Seyed Asadollah Mousavi (3)

Style	Citing Format
MLA	Gholami M, et al.. "Investigation of Cebpa and Cebpa-As Genes Expression in Acute Myeloid Leukemia." Reports of Biochemistry and Molecular Biology, vol. 7, no. 2, 2019, pp. 136-141.
APA	Gholami M, Bayat S, Manoochehrabadi S, Pashaiefar H, Omrani MD, Jalaeikhoo H, Yassaee VR, Ebrahimpour MR, Behjati F, Mirfakhraie R (2019). Investigation of Cebpa and Cebpa-As Genes Expression in Acute Myeloid Leukemia. Reports of Biochemistry and Molecular Biology, 7(2), 136-141.
Chicago	Gholami M, Bayat S, Manoochehrabadi S, Pashaiefar H, Omrani MD, Jalaeikhoo H, Yassaee VR, Ebrahimpour MR, Behjati F, Mirfakhraie R. "Investigation of Cebpa and Cebpa-As Genes Expression in Acute Myeloid Leukemia." Reports of Biochemistry and Molecular Biology 7, no. 2 (2019): 136-141.
Harvard	Gholami M et al. (2019) 'Investigation of Cebpa and Cebpa-As Genes Expression in Acute Myeloid Leukemia', Reports of Biochemistry and Molecular Biology, 7(2), pp. 136-141.
Vancouver	Gholami M, Bayat S, Manoochehrabadi S, Pashaiefar H, Omrani MD, Jalaeikhoo H, et al.. Investigation of Cebpa and Cebpa-As Genes Expression in Acute Myeloid Leukemia. Reports of Biochemistry and Molecular Biology. 2019;7(2):136-141.
BibTex	@article{ author = {Gholami M and Bayat S and Manoochehrabadi S and Pashaiefar H and Omrani MD and Jalaeikhoo H and Yassaee VR and Ebrahimpour MR and Behjati F and Mirfakhraie R}, title = {Investigation of Cebpa and Cebpa-As Genes Expression in Acute Myeloid Leukemia}, journal = {Reports of Biochemistry and Molecular Biology}, volume = {7}, number = {2}, pages = {136-141}, year = {2019} }
RIS	TY - JOUR AU - Gholami M AU - Bayat S AU - Manoochehrabadi S AU - Pashaiefar H AU - Omrani MD AU - Jalaeikhoo H AU - Yassaee VR AU - Ebrahimpour MR AU - Behjati F AU - Mirfakhraie R TI - Investigation of Cebpa and Cebpa-As Genes Expression in Acute Myeloid Leukemia JO - Reports of Biochemistry and Molecular Biology VL - 7 IS - 2 SP - 136 EP - 141 PY - 2019 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract